Cargando…
The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study
There is a lack of studies investigating the clinical benefits of prebiotic-supplemented infant formula. In this study, healthy infants that started, on medical recommendation, artificial feeding with one of 2 infant formulas containing 4 g/L of GOS/FOS (9:1) (IF4 group; n = 60) or 8 g/L of GOS/FOS...
Autores principales: | Tonon, Karina Merini, Tomé, Thaís Moreno, Mosquera, Elaine Martins Bento, Perina, Natália Pratis, Lazarini, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436285/ https://www.ncbi.nlm.nih.gov/pubmed/34527766 http://dx.doi.org/10.1177/2333794X211044115 |
Ejemplares similares
-
Effects of a Formula with scGOS/lcFOS (9:1) and Glycomacropeptide (GMP) Supplementation on the Gut Microbiota of Very Preterm Infants
por: Yu, Xue, et al.
Publicado: (2022) -
Dataset on the Life Cycle Assessment of fructo- and galacto-oligosaccharides (FOS and GOS) produced by synthesis or hydrolysis
por: Gerbino, Esteban, et al.
Publicado: (2022) -
HABITS AND ATTITUDES OF MOTHERS OF INFANTS IN RELATION TO BREASTFEEDING AND ARTIFICIAL FEEDING IN 11 BRAZILIAN CITIES
por: de Morais, Mauro Batista, et al.
Publicado: (2017) -
Supplementation With 2′-FL and scGOS/lcFOS Ameliorates Rotavirus-Induced Diarrhea in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2018) -
In Vitro Evaluation of the Effects of Commercial Prebiotic GOS and FOS Products on Human Colonic Caco–2 Cells
por: Lafontaine, Geraldine M. Flaujac, et al.
Publicado: (2020)